CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Impact of genetic concentrative nucleoside transporter variants on interferon/ribavirin therapy response in hepatitis C patients
DOI 10.1055/s-0031-1295873
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Rau, M Weisskopf, J Schmitt, S Russmann, B Müllhaupt, A Geier
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Treatment of HCV infection will change in the near future and direct acting antiviral drugs (DAA) will be added to existing antiviral therapy with peg-interferon-α and ribavirin (RBV). Side effects such as RBV-induced hemolytic anemia will be even worsened in combination with DAAs. Therefore, understanding of genetic host factors determining RBV bioavailability and therapeutic efficacy will remain crucial for…
Zitieren
Zitierempfehlung
M Rau, M Weisskopf, J Schmitt, S Russmann, B Müllhaupt, A Geier (2012) Impact of genetic concentrative nucleoside transporter variants on interferon/ribavirin therapy response in hepatitis C patients. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1295873
Mit CareLit weiterarbeiten